Literature DB >> 2734104

Nuclear protein factors and erythroid transcription of the human A gamma-globin gene.

F Catala1, E deBoer, G Habets, F Grosveld.   

Abstract

We have used DNaseI footprinting and gel mobility assays to analyze the upstream region of the human A gamma-globin gene promoter. Four protein factors were found to bind this region. A non-erythroid factor present in the 0.4M KCl fraction of a heparin agarose column binds to the CAC box (-140). A ubiquitous octamer factor present in the 0.2M fraction binds to an ATGCAAT element (-175), but is completed out by the erythroid specific factor NF-E1 (in the 0.4M KCl fraction), which binds a site (-186) immediately flanking the octamer. A novel factor binding to a stretch of 8A around -233, was identified in the 0.2M KCl fraction. This factor is not present in HeLa nuclear extracts. To study the transcriptional importance of these protein binding sites we have used an "A gamma-minilocus", similar to that described for the beta-globin gene (1) in K562 cells. This provides evidence that the NF-E1 and CAC box in the -210 to -122 region of the A gamma-promoter are important for the efficient expression of the gamma-globin gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2734104      PMCID: PMC317861          DOI: 10.1093/nar/17.10.3811

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin.

Authors:  T R Rutherford; J B Clegg; D J Weatherall
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

3.  Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes.

Authors:  H L Sive; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 4.  The molecular genetics of human hemoglobin.

Authors:  F S Collins; S M Weissman
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1984

5.  The HeLa cell protein TEF-1 binds specifically and cooperatively to two SV40 enhancer motifs of unrelated sequence.

Authors:  I Davidson; J H Xiao; R Rosales; A Staub; P Chambon
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

6.  The construction of cosmid libraries which can be used to transform eukaryotic cells.

Authors:  F G Grosveld; T Lund; E J Murray; A L Mellor; H H Dahl; R A Flavell
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Premature translation termination mediates triosephosphate isomerase mRNA degradation.

Authors:  I O Daar; L E Maquat
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

9.  Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor.

Authors:  R Schüle; M Muller; H Otsuka-Murakami; R Renkawitz
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more
  18 in total

1.  FKLF, a novel Krüppel-like factor that activates human embryonic and fetal beta-like globin genes.

Authors:  H Asano; X S Li; G Stamatoyannopoulos
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein.

Authors:  P A Ney; B P Sorrentino; C H Lowrey; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

3.  Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements.

Authors:  M Walters; D I Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

4.  A novel C-T transition within the distal CCAAT motif of the G gamma-globin gene in the Japanese HPFH: implication of factor binding in elevated fetal globin expression.

Authors:  S Fucharoen; K Shimizu; Y Fukumaki
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

5.  Functional profile of the human fetal gamma-globin gene upstream promoter region.

Authors:  H J Lin; C Y Han; A W Nienhuis
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

6.  Roles of fetal G gamma-globin promoter elements and the adult beta-globin 3' enhancer in the stage-specific expression of globin genes.

Authors:  C Perez-Stable; F Costantini
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

7.  A 46 base pair enhancer sequence within the locus activating region is required for induced expression of the gamma-globin gene during erythroid differentiation.

Authors:  B Sorrentino; P Ney; D Bodine; A W Nienhius
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

8.  Protein-DNA interactions upstream from the human A gamma globin gene.

Authors:  D O'Neill; J Kaysen; M Donovan-Peluso; M Castle; A Bank
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

9.  Increased Sp1 binding mediates erythroid-specific overexpression of a mutated (HPFH) gamma-globulin promoter.

Authors:  A Ronchi; S Nicolis; C Santoro; S Ottolenghi
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

10.  Discrimination among potential activators of the beta-globin CACCC element by correlation of binding and transcriptional properties.

Authors:  G A Hartzog; R M Myers
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.